|
瑞沙托维市场分析报告
|
Global Market Report of RESATORVID (CAS 243984-11-4) December 2024
CAS 243984-11-4 Resatorvid Chemical Report & Database ... Consumption Report & Database definitions: Name: Resatorvid: Resatorvid; (6R)-6-[[(2-Chloro-4-fluorophenyl)amino]sulfonyl]-1-cyclohexene ... -11-4 APPLICATIONS: Chemical or Reaction Intermediate The Resatorvid Report & Database gives Market Consumption ...
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019 Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019, provides an overview of the Liver ...
Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H2 2018 Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H2 2018 SUMMARY Toll Like Receptor 4 (hToll or CD284 or TLR4) - Toll-like receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly expressed in placenta, and in ...
Urea cycle disorders - Pipeline Insight, 2021 ... Heparesc ARCT 810 VS 01 KB195 HepaStem Resatorvid EVX-103 SG 328 Pegzilarginase ERY ...
Toll Like Receptor 4 - Pipeline Review, H2 2019 Toll Like Receptor 4 - Pipeline Review, H2 2019 SUMMARY Toll Like Receptor 4 (hToll or CD284 or TLR4) - Toll-like receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly expressed in placenta, and in myelomonocytic subpopulation of the ...
Acute On Chronic Liver Failure - Pipeline Insight, 2021 ... is a biopharmaceutical company pioneering the development of Resatorvid (TAK-242), a novel immunological therapy ...
Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Toll Like Receptor 4 (hToll or CD284 or TLR4) - Toll-like receptor 4 is a protein encoded by the TLR4 gene. ...
Hepatic Insufficiency/Liver Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034? The 7 major hepatic insufficiency/liver failure markets are expected to exhibit a CAGR of 3.79% during 2024-2034. The hepatic insufficiency/liver failure market has been comprehensively analyzed in IMARC's new report titled "Hepatic Insufficiency/Liver ...
|
|
|